Sep 2023 Bioprojet takes part in the 7th Garlaban Pediatric Day
On Saturday September 16, the 7th Garlaban Pediatric Day will take place. See you in Aubagne....
On Saturday September 16, the 7th Garlaban Pediatric Day will take place. See you in Aubagne....
The Cardiosleep Congress will take place from June 29th to July 1st. The Cardiosleep congress has brought together, since 2012, the greatest national and international sleep experts. Quality of presentations and conviviality have made this annual conference a reference in sleep medicine. Meet us in Ajaccio, Corsica....
The National Congress Ambulatory Pediatrics will take place on June 16th and 17th, 2023 For two days, professionals will address various themes of their outpatient practice: postnatal depression, connected pediatrics or emergencies at the office… Meet us in St Malo, France....
The Sleep Apnea Ventilation (SAV) Congress will take place from June 09 to June 10, 2023. Meet us at La Rochelle, in France. This year, the theme will be “The SAS, from easy to difficult. At the forefront of practice.” These days for health professionals will offer conferences...
On May 31th to June 2nd 2023 will take place the national congress “Congrès de la Société Française de Pédiatrie”. Meet us at the Parc Chanot, in Marseille, in France....
On April 25 - 28 2023 will take place the congress “Congrès Francophone d’Allergologie” (CFA). Meet us at the Palais des Congrès Porte Maillot, in Paris....
On April 25 - 28 2023 will take place the congress “Congrès Francophone d’Allergologie” (CFA). Meet us at the Palais des Congrès Porte Maillot, in Paris....
On April 20, 21 and 22, 2023 will take place the international congress “Sleep & Breathing” by the European Respiratory Society (ERS) in partnership with the European Sleep Research Society (ESRS). Meet us in Prague, Czech Republic....
The 24th edition of JIRP (Journées Interactives de Réalités Pédiatriques) will take place on March 23rd and 24th 2023. See you at the Palais des Congrès in Versailles....
The private biopharmaceutical company, Aculys Pharma, is launching a phase III therapeutic trial for excessive daytime sleepiness (EDS). The test patients in this trial have obstructive sleep apnea syndrome (OSA) and complain of EDS. This is manifested by upper airway obstruction, coupled with fatigue, drowsiness and...